Prospectively identified incident testicular cancer risk in a familial testicular cancer cohort


Pathak, A., et al. Prospectively identified incident testicular cancer risk in a familial testicular cancer cohort. Cancer Epidemiology Biomarkers and Prevention 24, 10, 1614–1621 (2015).


Background—Human testicular germ cell tumors (TGCT) have a strong genetic component and a high familial relative risk. However, linkage analyses have not identified a rare, highly-penetrant familial TGCT (FTGCT) susceptibility locus. Currently, multiple low-penetrance genes are hypothesized to underlie the familial multiple-case phenotype. The observation that two is the most common number of affected individuals per family presents an impediment to FTGCT gene discovery. Clinically, the prospective TGCT risk in the multiple-case family context is unknown. Methods—We performed a prospective analysis of TGCT incidence in a cohort of multipleaffected-person families and sporadic-bilateral-case families; 1,260 men from 140 families (10,207 person-years of follow-up) met our inclusion criteria. Age-, gender-, and calendar timespecific standardized incidence ratios (SIR) for TGCT relative to the general population were calculated using SEER*Stat. Results—Eight incident TGCTs occurred during prospective FTGCT cohort follow-up (versus 0.67 expected; SIR=11.9; 95% confidence interval [CI]=5.1–23.4; excess absolute risk=7.2/10,000). We demonstrate that the incidence rate of TGCT is greater among bloodline male relatives from multiple-case testicular cancer families than that expected in the general population, a pattern characteristic of adult-onset Mendelian cancer susceptibility disorders. Two of these incident TGCTs occurred in relatives of sporadic-bilateral cases (0.15 expected; SIR=13.4; 95%CI=1.6–48.6). Conclusions—Our data are the first indicating that despite relatively low numbers of affected individuals per family, members of both multiple-affected-person FTGCT families and sporadicbilateral TGCT families comprise high-risk groups for incident testicular cancer. Impact—Men at high TGCT risk might benefit from tailored risk stratification and surveillance strategies.

Publisher's Version

Last updated on 05/13/2022